Core Viewpoint - The company, Stone Four Pharmaceutical Group, has been actively repurchasing its shares, indicating a potential confidence in its stock value and future performance [2] Summary by Category Share Buyback Activity - On January 8, the company repurchased 1.486 million shares at a price range of HKD 3.030 to HKD 3.050, totaling HKD 4.5217 million [2] - The stock closed at HKD 3.050 on the same day, reflecting a 0.99% increase, with a total trading volume of HKD 20.5504 million [2] - Since January 5, the company has conducted share buybacks for four consecutive days, accumulating a total of 5.214 million shares repurchased, with a total expenditure of HKD 15.585 million [2] - During this period, the stock price has increased by 6.64% [2] Buyback Details - The detailed buyback information is as follows: - January 8: 1.486 million shares at a maximum price of HKD 3.050 and a minimum price of HKD 3.030, totaling HKD 4.5217 million [2] - January 7: 1.128 million shares at a maximum price of HKD 3.030 and a minimum price of HKD 3.010, totaling HKD 3.4063 million [2] - January 6: 1.500 million shares at a maximum price of HKD 3.000 and a minimum price of HKD 2.960, totaling HKD 4.4694 million [2] - January 5: 1.100 million shares at a maximum price of HKD 2.920 and a minimum price of HKD 2.890, totaling HKD 3.1876 million [2]
石四药集团(02005.HK)1月8日回购148.60万股，耗资452.17万港元